Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Catalent Applied Drug Delivery Institute to Host Symposium on Smart Drug Development and Design


The Catalent Applied Drug Delivery Institute today announced that along with Columbia University’s Lab-to-Market Accelerator Network and the Translational Therapeutics Accelerator (TRx), it will co-host a one-day symposium titled “Smart Drug Development & Design” at Columbia University, New York, on Wednesday, Oct. 2, 2019.

The symposium will be chaired by Cornell Stamoran, Ph.D., Co-Chair of the Catalent Applied Drug Delivery Institute, and will feature Mike Rea, CEO, IDEA Pharma, Jim Spavins, former Head of Pfizer’s Global PTx Pharmaceutical Sciences group, and a diverse group of industry leaders and researchers.

The first half of the symposium will help delegates understand the scientific concepts and technical know-how underpinning early preclinical studies. The second half of the day will transition the focus on strategies for successful drug products: patient-focused drug design; manufacturing; working with partners; and commercialization. The event will also give attendees the opportunity to apply what they have learned in an interactive audience participation session.

Registration and full details of the agenda can be found at http://www.drugdeliveryinstitute.com/events/smart-drug-development-design-workshop/.

About Catalent Applied Drug Delivery Institute

Catalent’s Applied Drug Delivery Institute was founded in 2012 to serve as a link between industry and academia, advance education and training in drug delivery in academia and the industry, accelerate adoption of applied drug delivery technologies to develop better treatments, and foster industry collaboration on major issues pertaining to drug development, formulation, and delivery. It is pursuing a multi-tiered approach of research, strategic counsel, and educational programs to advance the adoption of drug delivery technologies to improve patient outcomes.

For more details on the Catalent Institute, visit https://www.drugdeliveryinstitute.com and follow the Catalent Institute on Twitter: @DrugDeliveryIns

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs nearly 13,000 people, including approximately 2,400 scientists, at more than 35 facilities across five continents, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

As Cannabis Industry Sales Approach $5 Billion This Year, Irwin Naturals Launches more than 100 CBD Products to Help Stores Keep Up with Demand


Irwin Naturals Leads the CBD Health Craze with 100 New CBD Products

We got lucky! We took a chance two years ago that the law would go our way. Now we’re the only legacy company with mass market relationships and a broad line of CBD products ready to launch

25-year old legacy company, Irwin Naturals, will introduce dozens of new cannabidiol (CBD) products next month and announce its ambitious market projections in CBD distribution. The announcement comes after the company’s 2-year R&D head-start against other legacy companies in the CBD products space.

With the FDA and federal lawmakers expected to curtail rules restricting CBD distribution this fall, industry experts predict a land grab is about to begin for retail shelf space and distribution channels of CBD brands in the mass market. While new CBD companies can achieve distribution in health food stores and dispensaries, retail industry experts believe mainstream pharmacies and grocery stores will prefer to partner with longstanding, well-established legacy companies with proven, scalable distribution channels. Irwin Naturals, a leading international supplier of high quality natural health, herbal and nutritional supplements, may be the front runner in the race to dominate the booming CBD market because of a gamble the company took two years ago.

In late 2017, at a time when few industry experts and virtually no consumers knew about CBD or its health benefits, Irwin Naturals began investment in the development of over 100 different products infused with cannabidiol, a compound found in cannabis plants. The decision to invest came nearly two years earlier than most of its largest competitors. Company managers, including founder Klee Irwin, predicted that the market would explode in popularity once U.S. lawmakers passed legislation that would legalize the cultivation of hemp and the sale of products derived from hemp. Their prescient gamble paid off on December 20th, 2018, when President Donald Trump signed the Agricultural Improvement Act, legislation that lifted restrictions on hemp and CBD product development, effectively giving a first-mover advantage to Irwin Naturals.

Now, Irwin’s CBD products are ready to hit the mass market in a rapid sweep. Over 100 CBD products, spread across four brand categories, were birthed from Irwin’s R&D effort. The brands are; the Irwin Naturals brand for CBD infused oil drops, supplements and balms; HydroCanna for CBD skincare; FloChi for CBD based foods and beverages and Love My Pet for animals.

According to the Brightfield Group, a Chicago-based market research firm studying the industry, U.S. sales of CBD products is projected to hit $5 billion by the end of the year, an increase of more than 700% compared with 2018 sales. The firm also predicts the CBD market will surpass $22 billion in annual sales by the year 2022. Typically, more than 80% of all sales in particular consumer product categories occur in mass market outlets and warehouse chains where Irwin Naturals has longstanding distribution relationships. In fact, because of the relationships it maintains with the largest warehouse chains in the U.S., Irwin Naturals managers predict the company will be the distribution leader in the land-grab toward market dominance of this disruptive new mega-category.

The Brightfield Group also published an article stating, “Irwin Naturals is well-positioned to effectively leverage existing distribution networks and customer relationships to market products already tied to a trusted brand.” In addition, the Green Market Report, a publication focused on financial news rapidly growing cannabis industry said, “Irwin Naturals turned heads when Klee Irwin, the founder of the company, announced giving away $1 million worth of CBD products to honor the passing of the Farm Bill. The company is concerned with making the cost of CBD products affordable, saying ‘Our mission is to spread health to the world through plant medicine. Our nation is on the edge. And I am worried about the future of our children. If we can make CBD affordable and accessible to the masses, it just might help our country avoid a meltdown.’”

Founder Irwin, author of the CBD book, Pain Nation, said, “We got lucky. We took a chance two years ago that the law would go our way. Now, we’re sort of alone as the only large legacy company with strong mass market relationships and a broad line of CBD products ready to launch. For decades, we’ve sold to over 100,000 outlets in the US alone. In the last eight months, we’ve secured agreement from nearly all of the largest chains to take our CBD products. Money is not our primary motivation. We want to get CBD to people at a lower cost – the type of cost anyone can afford. And our chain store partners love this philosophy. So, we’ve been selected for first distribution of our products by most of the big chains versus the smaller and higher priced CBD companies that sell products online or to dispensaries. In the future, our large competitors will also enter the CBD space. But, for now, we can easily execute our national mindshare branding and distribution strategy and be the dominate player when the smoke clears in the next few years to reveal the pending $20+ billion CBD industry.’”

Share article on social media or email:

Rx relief® Makes Staffing Industry Analysts’ 2019 List of Largest Allied Healthcare Staffing Firms in the U.S. for Second Consecutive Year


Rx relief logo

Rx relief logo

Rx relief continues to grow as a leader in this segment by providing the industry’s best temporary and full-time pharmacy professionals in all types of pharmacy organizations.

Rx relief, a division of PrideStaff, is pleased to announce that their pharmacy recruiting and placement firm was once again named to Staffing Industry Analysts’ list of Largest Allied Healthcare Staffing Firms in the United States. This is the second consecutive year Rx relief has made this list, moving up from number 28 in 2018 to number 27 in 2019.

Reflecting continued robust growth within the U.S. healthcare staffing market, each of the elite organizations named to this list generated over $25 million in U.S. staffing revenue in 2018. According to Staffing Industry Analysts (SIA) estimates, these organizations collectively generated more than $2.3 billion in U.S. allied healthcare temporary staffing revenue last year, accounting for 58% of the market. For the purposes of the report, SIA defined “allied healthcare” temporary staffing firms as those providing temporary healthcare professionals such as therapists (physical, occupational and speech), imaging technicians, phlebotomists and pharmacists.

“We’re thrilled to be named as one of the largest U.S. allied healthcare staffing firms for a second straight year,” said George Rogers, Founder and CEO of PrideStaff. “Rx relief continues to grow as a leader in this segment by providing the industry’s best temporary and full-time pharmacy professionals in all types of pharmacy organizations. As demand for qualified professionals remains strong, we will continue to support the success of our clients and talent by living out our mission to ‘Consistently provide client experiences focused on what they value most,’ every day.”

Making SIA’s 2019 list is just the latest mark of distinction for the leading pharmacy recruiting and placement firm. Earlier this year, Rx relief also earned ClearlyRated’s coveted Best of Staffing® Client and Talent Diamond Awards for a fifth consecutive year, after winning the Best of Staffing Client and Talent Awards at least five years in a row for providing superior service to their clients and job seekers. Rx relief is the only staffing firm dedicated to pharmacy staffing in the U.S. and Canada to win the Diamond Awards five years in a row.

About Rx relief

A division of PrideStaff, Rx relief is a Joint Commission Certified and GSA approved pharmacy placement firm providing temporary and full-time pharmacy professionals for all pharmacy practice settings. The parent company was founded in the 1970s as 100% company-owned units and began staffing franchising in 1995. They operate over 80 offices in North America to serve over 5,000 clients. With over 40 years in the staffing business, headquartered in Fresno, CA, all PrideStaff brands offer the resources and expertise of a national firm with the spirit, dedication and personal service of smaller, entrepreneurial firms. For more information on Rx relief services, visit http://www.rxrelief.com.

PrideStaff and Rx relief’s shared Mission: Consistently provide client experiences focused on what they value most.

Share article on social media or email:

Seattle, WA Dentist, Dr. Paul Amato, Enhances Dental Implant Expertise at SPEAR® “All-on-X” Course


Dr. Paul Amato, Seattle, WA Cosmetic Dentist at LeCuyer & Amato Dentistry

Cosmetic Dentist, Dr. Paul Amato, Attends SPEAR® “All-on-X” Full Mouth Dental Implant Course

The All-on-X Spear Education course gave me a huge base of knowledge to be able to treat these types of patients in my practice comfortably and with expertise.

Esteemed cosmetic dentist, Dr. Paul Amato, recently completed an extensive “All-on-X” study club with SPEAR®, the leaders in dental education. This course helped enhance Dr. Amato’s expertise in full mouth dental implants, which he offers as a premium tooth replacement solution at his Seattle, WA office, LeCuyer & Amato Dentistry.

With over a dozen dentists and specialists participating, attendees of the SPEAR “All-on-X” course collaborated to expand their knowledge and expertise on full mouth dental implant treatment. Dr. Amato was joined by peers who enhance their education and understanding of general dentistry and dental implant techniques at every opportunity.

The course was held in Phoenix, AZ and was facilitated by periodontist, Dr. Brad Weinstein. Dr. Weinstein guided the conversation, which included:

  • Diagnosing the patient
  • Accurate treatment planning
  • Possible complications and how to avoid them
  • Covering the treatment process from A-Z

Participating in 80-100 hours annually, Dr. Amato will attend the follow-up class to the “All-on-X” course this fall in order to gain an even a deeper understanding of how to best provide this treatment to each of his patients. “The All-on-X Spear Education course gave me a huge base of knowledge to be able to treat these types of patients in my practice comfortably and with expertise,” says Dr. Amato of his experience.

All-on-X is a type of full mouth dental implant treatment that is used for those with extensive tooth loss. With this treatment, dental implants are placed into the jawbone and used to firmly secure a full arch prosthesis of new teeth. The number of implants used in the treatment represents the X in the treatment name and is determined on a case-by-case basis dependent on patient needs. With proper care of these new teeth, patients can enjoy a lifetime of healthy and fully functional use of their mouth.

Dr. Amato works along with Drs. Chris LeCuyer and Lauren Kopp to provide state-of-the-art restorative and cosmetic dentistry to Seattle, WA at LeCuyer & Amato Dentistry. This practice helps patients achieve smiles that are not only functional, but attractive and complementary to their overall facial aesthetics. The practice offers many beautiful cosmetic dentistry solutions, including the Bioclear Matrix method, porcelain veneers, Invisalign® and full arch dental implants for those in need of a full mouth tooth replacement option.

Those interested in learning more about dental implants in Seattle, WA can schedule a consultation with Drs. Amato, LeCuyer, or Kopp by contacting the practice at 206-626-5400 or visiting the website at http://www.lecuyeramato.com.

About the Dentists

LeCuyer & Amato Dentistry has brought industry leading cosmetic dentistry treatments to Seattle, WA for over 30 years. Dr. Paul Amato is passionate about his community and offers pro bono dental care through organizations like Jewish Family Services and the King County Dental Society. He actively attends continuing education courses to remain on the leading edge of his field, and has advanced training certifications from prestigious institutions including the American Academy of Cosmetic Dentistry and the Kois Center. Dr. Chris LeCuyer has over 30 years of experience in cosmetic dentistry and has lent his expertise to the Academy of General Dentistry and the American Dental Association. Dr. Lauren Kopp received her Doctorate of Dental Surgery from the University of Washington and regularly participates in continuing education courses to gain skills that will improve her patients’ health. These esteemed cosmetic dentists offer the most advanced treatments including the Bioclear Matrix, Invisalign®, and full arch dental implants. The team at LeCuyer & Amato Dentistry is committed to maintaining a standard of excellence in everything they do, providing the highest quality of care and precise results. To learn more about LeCuyer & Amato Dentistry and the industry leading cosmetic dentistry services they offer, visit their website at http://www.lecuyeramato.com, or call the office at 206-626-5400.

Share article on social media or email:

Gauss Announces Triton Platform Update to Power Maternal Hemorrhage Response


News Image

We have adopted the Triton platform across multiple facilities at Providence, and the integration of hemorrhage protocols and provider alerts will help us to deliver the best quality of maternal care, consistent with the Joint Commission’s new perinatal safety standard.

Gauss, the leader in AI-enabled surgical applications, announced an over-the-air software update, Triton QBL, that pairs the company’s AI-powered blood loss monitor with integrated protocols and provider alerts that help to synchronize postpartum hemorrhage care. The update will be available to the company’s network of hospital customers this fall.

The United States has the highest maternal mortality rate in the developed world (1). According to the Centers for Disease Control and Prevention (CDC), 60 percent of pregnancy-related deaths are preventable (2). Postpartum hemorrhage is the leading preventable cause of maternal morbidity and mortality (3), and obstetrics organizations such as the American College of Obstetrics and Gynecology (ACOG) and the California Maternal Quality Care Collaborative (CMQCC) recommend use of standardized hemorrhage management protocols (4,5).

On August 21, 2019, The Joint Commission, the body that accredits approximately 77 percent of hospitals in the United States, announced a perinatal safety guideline that requires accredited hospitals to “develop written, evidence-based procedures for stage-based management of pregnant and postpartum patients who experience maternal hemorrhage” incorporating “the use of an evidence-based tool that includes an algorithm for identification and treatment of hemorrhage.” (6) This new standard will go into effect July 1, 2020.

“Management of maternal hemorrhage with stage-based protocols based on cumulative, quantitative blood loss is imperative for safe obstetric care,” said David Lagrew, M.D., executive medical director of Women’s Services at Providence St. Joseph’s Health and co-chair of the CMQCC Maternal Quality Care Collaborative’s Hemorrhage Task Force. “We have adopted the Triton platform across multiple facilities at Providence, and the integration of hemorrhage protocols and provider alerts will help us to deliver the best quality of maternal care, consistent with the Joint Commission’s new perinatal safety standard.”

Triton is the only FDA-cleared and CE Marked system for blood loss monitoring in surgery and obstetrics. It leverages computer vision and the CoreML capability of the iPad and iPhone to monitor blood loss from images captured by the TrueDepth sensor. Triton adoption has grown by more than 100 percent year-over-year, and Gauss’s U.S. customers perform approximately 250,000 deliveries per year (7). Researchers at Mount Sinai Hospital in New York recently published an independent 7,600 patient study in the International Journal of Obstetric Anesthesia on the use of Triton to power a stage-based hemorrhage protocol. The use of Triton was associated with a 340 percent increase in hemorrhage recognition, a 34 percent reduction in delayed interventions to control bleeding in vaginal deliveries, reduced transfusion dose in Caesarean sections, and cost savings leading to a 152 percent return on investment (8).

Triton QBL is compatible with both iPhone and iPad platforms and enables hospitals to embed their own hemorrhage protocols and set customized alerts based on quantified blood loss (QBL) thresholds, delivering real-time guidance to clinicians and facilitating communication and rapid response during an emerging hemorrhage. U.S. hospitals are rapidly adopting smartphones to improve communication and collaboration among clinical teams (9), and Triton’s new iPhone compatibility delivers a mobile platform that enables health systems to leverage their IT investment in enterprise-issued phones.

“We are incredibly excited about this significant evolution of the Triton system to power hemorrhage protocols and support better maternal care,” said Siddarth Satish, founder and chief executive officer of Gauss. “With hundreds of thousands of enterprise-issued iPhones in use by clinical staff in hospitals today, these latest developments enable us to extend the benefits of our AI-enabled patient safety platform to many more patients and healthcare providers.”

About Gauss

Gauss is transforming surgery with an AI-enabled mobile platform for the operating room. Based in Silicon Valley, the company leverages computer vision, machine learning, and artificial intelligence to power surgical safety protocols by delivering real-time insights, simplifying clinical workflow, and closing communication gaps. The company’s flagship Triton platform is FDA cleared and CE Marked and powers maternal hemorrhage protocols in hospitals performing over 250,000 annual deliveries. Triton received the 2018 Apple Design Award, which recognizes the best in design, innovation and technology on Apple platforms. For more information, visit http://www.gauss.com.

(1) Kassebaum NJ, Barber RM, Bhutta ZA, et al; GBD 2015 Maternal Mortality Collaborators. Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1775-1812.

(2) Petersen EE, Davis NL, Goodman D, Cox S, Mayes N, Johnston E, et al. Vital signs: pregnancy-related deaths, United States, 2011-2015, and strategies for prevention, 13 states, 2013-2017. MMWR Morb Mortal Wkly Rep 2019;68:423–9.

(3) Ibid.

(4) https://www.acog.org/About-ACOG/News-Room/News-Releases/2017/ACOG-Expands-Recommendations-to-Treat-Postpartum-Hemorrhage?

(5) https://www.cmqcc.org/resources-tool-kits/toolkits/ob-hemorrhage-toolkit

(6) https://www.jointcommission.org/assets/1/6/New_Perinatal_Standards_Prepub_Report.pdf

(7) American Hospital Association Data and Gauss Internal Estimates

(8) Katz D, Wang R, O’Neil L, Gerber C, Lankford A, Rogers T, Gal J, Sandler R, Beilin Y., et al. The association between the introduction of quantitative assessment of postpartum blood loss and institutional changes in clinical practice: an observational study. Int J Obstet Anesth. 2019 May 13. pii: S0959-289X(19)30070-6. doi: 10.1016/j.ijoa.2019.05.006. [Epub ahead of print]

(9) https://www.beckershospitalreview.com/healthcare-information-technology/survey-90-of-hospitals-investing-in-smartphones-for-clinical-communication.html

Share article on social media or email:

USA’s Largest Gluten-Free Food Festival Returns to Secaucus, NJ at the Meadowlands Exposition Center October 5-6 2019


https://www.prweb.com/

Secaucus Gluten-Free Festival – October 5th-6th at the Meadowlands Exposition Center

“From comfort foods to healthy lifestyle options, this festival truly offers something for everyone. An event of this scale being accessible to the general public is a rare and exciting way to explore new options and sample products before buying them in store.” -Jen Cafferty, Founder and CEO

Nourished: The Gluten Free, Allergy & Specialty Diet Festival, formerly The Gluten Free & Allergen Friendly Expo, is returning to New Jersey again this fall! The Nourished Festival and its team are incredibly excited to come back to Secaucus and the Meadowlands Exposition Center. The Secaucus stop of the Festival will take place Saturday October 5th and Sunday October 6th 2019.

In 2019, all Nourished Festival locations will provide expanded offerings to better accommodate the most popular food lifestyles. In addition to the existing Gluten-Free and Nut-Free zones, Paleo, Keto, and Plant-Based products will bring variety and educational opportunities to everyone living a gluten-free lifestyle. As in the past, all products at the festival will be gluten free.

At the Nourished Festival, attendees will have one-on-one moments with over 120 brands exhibiting the best products for food sensitivities, food allergies and specialty diets. The festival also provides the opportunity to sample and purchase products, meet founders, receive coupons and attend free educational presentations hosted by industry-respected speakers.

While all products at the Festival are gluten free, many exhibitors will also showcase products free from the top eight allergens – and beyond. The Nourished Festivals are managed by The Nourished Group, with a team fluent in gluten-free living, celiac disease, and food allergies – and the rising need to find safe and delicious food and lifestyle products for any specialty diet. Presented by allergen-friendly sponsor Enjoy Life Foods, this event is family friendly and ideal for anyone following a specialty diet lifestyle.

“Our festivals nourish the needs of the entire food community – whether its those with celiac disease, autism, autoimmune or inflammatory conditions or those committed to living a healthy lifestyle,” says Nourished Festival founder, Jen Cafferty. “With comfort foods like pizza and baked goods to healthy lifestyle options like protein bars and probiotic drinks, this festival truly offers something for everyone. An event of this scale being accessible to the general public is a rare and exciting way to explore new options and sample products before buying them in store.”

A sample of this year’s exhibitors includes:


Tickets can be purchased in advance or at the door. A one-day ticket is $15 for adults and $5 for children at the door.

FOR MORE INFORMATION

Website: https://nourishedfestival.com/

To schedule TV/radio/print coverage, or for a complimentary press pass, contact Erica Dermer at erica@nourished.group.

ABOUT NOURISHED: THE GLUTEN FREE, ALLERGY & SPECIALTY DIET FESTIVALS

Managed by The Nourished Group, formerly The Gluten Free Media Group, Nourished: The Gluten Free, Allergy & Specialty Diet Festivals are the largest and fastest growing specialty diet consumer events in the United States. Started in 2007, the events have expanded from one city to multiple US cities including Secaucus, NJ. The festivals cater to anyone looking to lead a healthier lifestyle or those who follow a modified diet due to food sensitivities, allergies or intolerances. Offerings including Paleo, Keto, Plant-Based, Gluten-Free and Nut-Free products. The events provide opportunities for attendees to sample and purchase new products, receive coupons, meet with brand ambassadors and attend educational classes with industry experts. For more information, visit their website or find them on Facebook, Twitter and Instagram.

Share article on social media or email:



Increasing Patient Compliance with Remote Patient Monitoring


InfoBionic is a digital health company transforming the efficiency and economics of ambulatory remote patient monitoring processes by optimizing clinical and real-world utility for the users that need it most – physicians and their patients.

Stuart Long, CEO of InfoBionic, underscores how to increase patient compliance with cardiac monitoring.

“Remote patient monitoring not only gives people convenient access to their healthcare provider, but also a tangible connection to their own health.”

Lack of patient compliance is a well-known source of frustration for physicians, particularly when it comes to people with chronic health conditions. Remote patient monitoring (RPM) can lead to greater patient engagement, which in turn can elevate compliance with physician recommendations, including taking medications as prescribed and making important lifestyle changes, said InfoBionic CEO Stuart Long.

While it’s counterproductive to ignore what physicians advise us, well-established human behavior has proven that we don’t always do what’s best for us. Not only that, patients who are only told what to do are less engaged and compliant than those who can see positive changes from following physician instructions, said Long, whose Massachusetts-based company makes a non-invasive, full-disclosure remote cardiac monitor.

Some healthcare experts call medical noncompliance a national epidemic [1].

“Patient engagement happens when patients take ownership of their health,” Long said. “Remote patient monitoring not only gives people convenient access to their healthcare provider, but also a tangible connection to their own health. That has a significant impact on engagement and compliance.”

It also can reduce healthcare costs. Eighty-six percent of healthcare costs are for people with chronic conditions, including diabetes, obesity, cardiovascular disease and dementia, according to data published in 2017 in the American Journal of Preventive Medicine [2]. A 2015 study in American Journal of Managed Care found that people who received the most healthcare, especially patients with more than one chronic condition, were five times more likely to need emergency department services [3].

Philadelphia cardiologist Colin Movsowitz, M.D. said that patients are far more likely to correctly wear a remote monitor when its operation is easy to understand, and it is simple and convenient to wear. This is especially important with older patients who may not be tech savvy, he said.

“The value of easy-to-use remote cardiac monitoring is tremendous,” Dr. Movsowitz said. “Not only because of the clinical data that we wouldn’t get any other way, but also because of the increased level of patient engagement, compliance and satisfaction.”

Patients, especially younger ones, want to use RPM and other telemedicine technology, according to Accenture’s 2019 Digital Health Consumer Survey, which found that 53 percent of patients surveyed said they are more likely to choose a primary care provider who uses remote or telemonitoring devices [4]. A 2018 survey by Black Book found that 84 percent of patients want providers who use technology that helps them communicate with their doctors and engage with their own health data [5].

In 2016, seven million people were using remote monitoring and other internet-connected medical devices, according to a report by Berg Insight. By 2021, that number is expected to increase to more than 50 million [6].

About InfoBionic

InfoBionic is a digital health company transforming the efficiency and economics of ambulatory remote patient monitoring processes by optimizing clinical and real-world utility for the users that need it most – physicians and their patients. The Massachusetts-based team of seasoned entrepreneurs have had successful careers in healthcare, IT, medical devices and mobile technology, and bring specific expertise in remote monitoring and cardiology. They have seen first-hand the complexities of traditional cardiac arrhythmia detection and monitoring processes and designed the transformative MoMe® Kardia platform to remove the roadblocks hindering faster, more effective diagnosis and decision-making. Frost & Sullivan bestowed the 2019 North American Remote Cardiac Monitoring Technology Leadership Award upon InfoBionic. For more information visit http://www.infobionic.com

About MoMe® Kardia

The company’s flagship product, the MoMe® Kardia 3-in1 monitor, is the first non-invasive remote cardiac monitor to offer truly full disclosure, heartbeat-to-heartbeat data over the Cloud, allowing doctors 24/7 real-time access to hospital telemetry-level data. With the MoMe® Kardia, doctors will be able to eliminate third-party monitoring data services and take full ownership of the cardiac monitoring process, empowering them to realize lucrative new revenue streams by billing globally for the monitoring service. MoMe® Kardia is not intended for use as an emergency medical response system. Call 911 if you feel you are having a medical emergency.

1. Scarlett, William, and Steve Young. “Medical Noncompliance: The Most Ignored National Epidemic.” The Journal of the American Osteopathic Association, American Osteopathic Association, 1 Aug. 2016.

2. Chapel, John M, et al. “Prevalence and Medical Costs of Chronic Diseases Among Adult Medicaid Beneficiaries.” American Journal of Preventive Medicine, U.S. National Library of Medicine, Dec. 2017.

3. Owens, Gary. “Economic Burden of Multiple Sclerosis and the Role of Managed Care Organizations in Multiple Sclerosis Management.” AJMC, 31 May 2016.

4. Safavi, Kaveh. “Today’s Consumers Reveal the Future of Healthcare.” Accenture.

5. Research, Black Book. “Hospital Technology Is the New Determiner of Patient Satisfaction, 2018 Black Book EHR User Survey Results.” PR Newswire: Press Release Distribution, Targeting, Monitoring and Marketing, 27 June 2018.

6. Insight, Berg. MHealth and Home Monitoring.

Share article on social media or email:

Horizon Photography to Provide Official Event Photos of First GRIN2B Foundation Fundraiser


Horizon Photography Logo.

Funding research on GRIN2B-Related Neurodevelopmental Disorder is an extremely important cause, and I’m happy to do anything I can to help families and individuals affected by this rare condition.

Horizon Photography will provide the official event photos of Gather for GRIN2B, GRIN2B Foundation’s first cocktail reception fundraiser. The event will be held on Monday, October 7 from 6 p.m. to 9 p.m. at Found Kitchen and Social House in Evanston.

Proceeds will go toward funding research on GRIN2B-Related Neurodevelopmental Disorder, a rare condition caused by variations on the GRIN2B gene.

“I’m really looking forward to helping get the word out about GRIN2B Foundation’s first cocktail reception fundraiser,” said Jennifer Schuman, owner of Horizon Photography. “Funding research on GRIN2B-Related Neurodevelopmental Disorder is an extremely important cause, and I’m happy to do anything I can to help families and individuals affected by this rare condition. If you know Kevin Rubin and his work in the community, you know he goes beyond to help others, so this is the perfect time to pull together with him in this effort.”

Rubin is the president and CIO of Stratosphere Networks, one of the sponsors of Gather for GRIN2B. Some other corporate sponsors include Little Steps Pediatric Therapy, Accounting Concepts, Avalon Realty Associates, Lubin Austermuehle, P.C., and Rothman Law Group.

GRIN2B Foundation is a parent-run organization dedicated to providing support for those affected by GRIN2B variations and furthering research on the GRIN2B gene, which is part of a family of seven genes that encode proteins to create a receptor the sends chemical messages between neurons.

Symptoms of GRIN2B-Related Neurodevelopmental Disorder can include speech delay or lack of speech, developmental delays, and low muscle tone. Individuals affected by this disorder might also experience associated conditions such as cortical visual impairment, seizures, Autism Spectrum Disorders, Attention Deficit Hyperactivity Disorder, and/or intellectual disabilities.

To learn more about Gather for GRIN2B and get tickets, please go to http://www.grin2b.org/Gather-For-GRIN2B/. For information about sponsorship, visit http://grin2b.org/sponsor.

About Horizon Photography

Horizon Photography is a boutique Evanston-based photo studio focused on providing creative content and assisting with personal branding. Founder Jennifer Schuman leverages her art and design background to tell her clients’ unique stories with artistic flair. To learn more, please visit http://www.horizon-arts.com.

For more information contact:

Jennifer Schuman

847-910-2722

jennifer@horizon-arts.com

Share article on social media or email:

ImPACT Applications and HeadSmart Concussion Programme Partner to Expand Concussion Management in Australia and South Africa


ImPACT Applications is excited to offer its best-in-class products and services to a wider population in Australia and South Africa.

ImPACT Applications, Inc., the leading provider of concussion assessment tools cleared by TGA, FDA, Health Canada, and other regulatory agencies worldwide, announced a new collaboration with HeadSmart™, the leading distributor of online concussion testing in Australia and South Africa. This partnership makes ImPACT Applications’ tools available to athletes at all levels in Australia and South Africa through the HeadSmart Concussion Programme.

“ImPACT Applications is excited to offer its best-in-class products and services to a wider population in Australia and South Africa,” said Michael Wahlster, Chief Executive Officer of ImPACT Applications. “The collaboration with HeadSmart will extend our reach significantly and enable us to supply healthcare providers in both countries with the validated tools and world-class support and training needed to identify and manage concussions.”

ImPACT Applications offers ImPACT neurocognitive baseline and post-injury testing that student-athletes can obtain through the HeadSmart Concussion Programme. This helps schools and sports clubs strengthen their concussion protocols while promoting player safety. Healthcare providers can also leverage ImPACT clinical reports and other patient data to make objective treatment decisions.

“This partnership with ImPACT Applications provides access to proven tools that bridge the gap between patients and healthcare providers,” said Dr. Ryan Kohler, Managing Director of HeadSmart and Specialist Sports Physician. “It was the right step to take in ensuring student-athletes at all levels receive the gold standard in neurocognitive concussion testing.”

Learn more about ImPACT Applications’ tools and training courses here https://impacttest.com.

About ImPACT Applications

ImPACT Applications, Inc. is the maker of ImPACT®, ImPACT Pediatric®, and ImPACT Quick Test®, medical devices that assist in the screening, assessment, and management of concussion. In addition, ImPACT Applications provides tools, training, and credentialing programs to healthcare providers worldwide.

ImPACT Applications products are used by thousands of major medical centers, professional sports leagues and teams, colleges, high schools, and select military units around the globe.

About HeadSmart Sports Concussion Programme

The HeadSmart Sports Concussion Programme offers an end-to-end sports concussion solution for grassroots schools and clubs to the same standard as professional teams. The HeadSmart Sports Concussion Programme is the point of entry to a network of medical practitioners who can manage sports concussion.

With their Ready Recognise Refer approach, they supply a packaged online educational webinar, approved baseline computerized screening, post-concussion assessments, and the on-site FirstResponder™ head injury App. HeadSmart is a front-end fit to compliance with national sporting organizations’ concussion protocols, promoting athlete and player safety as directed by the doctor.

Share article on social media or email:

Animal Health: A Promising Market with Rapid Growth


China’s animal health market reached 4 billion euros (or 1 billion RMB) in 2017, and is expected to reach 9 billion euros (or 70 billion RMB) in the next seven years.

2019 Echemi Animal Health Industry Analysis Forum, organized by Echemi and VNU Exhibitions Europe, was held at Hall S3, Qingdao Cosmopolitan Exposition. Currently, related enterprises are benefited a lot from the rapid growth of the animal health industry and great market demand home and abroad. Following the market trend, Echemi focuses on the animal health industry to explore potential value. It is the fifth industrial forum organized by Echemi. During the forum, David Zhang, the founder of Echemi, and experts from China, Bangladesh, Vietnam, Ukraine and Argentina were invited to share the development trend of the animal health industry with more than 20 global buyers and over 70 Chinese suppliers. By doing so, Echemi and the global partners will know more about the market demand and seek a win-win scenario.

At 9:30 a.m., David Zhang firstly made an opening speech, showing the warmest welcome to all the distinguished guests. And then, he made an in-depth analysis of the animal health market.

“Through years of development, the global animal health market has entered a period of stability. In addition to the negative growth in 2009 due to the global financial crisis, the animal health market has maintained a steady growth. The market size increased from $13.7 billion in 2004 to $31.9 billion in 2018, with a compound annual growth rate of 5.7%.

The market size of China’s animal health industry still lags far behind world leading countries. However, with the gradual attention paid by the country to animal epidemic prevention and control and food safety, the domestic animal health industry has developed rapidly and maintained a relatively upward trend. China’s animal health market reached 4 billion euros (or 1 billion RMB) in 2017, and is expected to reach 9 billion euros (or 70 billion RMB) in the next seven years.” David Zhang said on the opening ceremony.

Professor Zou Ming from Qingdao Agricultural University delivered a speech entitled Market of Animal Health Industry & Research of New Veterinary Drug. In his speech, Professor Zou introduced current research situation of domestic and foreign animal health market, and research status of new veterinary drugs in China and beyond. He pointed out, “In the past 10 years, the veterinary drug industry has gradually formed an industrial system with complete categories, diverse varieties, advanced technology, complete industrial chain. API and some pharmaceutical products have international competitiveness.”

Mr. Mohammad Shaheen Shah gave a detailed analysis about the feed market in Bangladesh. Taking the market demand, livestock population and products in Bangladesh as examples, Mr. Mohammad Shaheen Shah stated that, the trends of feed additive were shifting meat & bone meal (MBM) to alternative protein and shifting antibiotic to antibiotic substitute. Besides, feed miller were looking for antibiotic substitutes such as organic acids, phytobiotics, prebiotic, probiotic, symbiotics, immune stimulants, sssential oils, and herbal extracts.

Mr. Nguyen Viet Anh analyzed the animal market in Vietnam. From the perspective of the feed market in Vietnam, Mr. Nguyen Viet Anh introduced the character of and challenges facing with the husbandry market in Vietnam, pointing out that the industry was shifting into intensification. In 2014, the government promulgated the livestock restructuring plan, which aimed to restructure livestock production, envisage changes in the livestock population’s spatial distribution, in farming systems, and in value chains, along with institutional strengthening. Currently, there are 66 companies meeting GMP standard, producing and distributing with 6,768 medicines on the list of veterinary drugs permitted for circulation and more than 3,000 medicines of 40 importing countries.

Dr. Fedir Marchenkov delivered a speech entitled Ukraine Feed Market Analysis. In his speech, Dr. Fedir Marchenkov introduced the feed market in Ukraine, main problems for livestock, and products trend. In terms of beef export in Ukraine, he pointed out that “Ukraine has been successful in developing export markets for their cattle in Central Asia, Caspian Sea countries, and North Africa. There will be no significant export destination changes are expected in 2019.” However, the Africa swine fever, infectious diseases and contamination in feed are tough issues that the global husbandry industry needs to deal with.

Finally, Ms. Eugenia Campanelli took the pet food market in Argentina as an example to introduce the feed industry in Latin America. She pointed out that in 2018, 720 million tons of animal feed was produced around the world, and Latin America and the Caribbean were responsible for 120 million tons, representing 17% of global production. Latin America and the Caribbean are important producers, consumers and exporters of grains and cereals, pork, poultry, cattle, and aquatic products. The region is the leader of the animal industry.

At 1:00 p.m., Echemi guided tour began. Buyers were divided into two groups to visit Hall S2 for feed products and Hall S3 for animal health products respectively according to their demands, and exchanged product information with many exhibitors on site. Through this activity, overseas buyers can get more information about Chinese suppliers, and in return, suppliers can also use this opportunity to display their production and sales capabilities.

2019 Echemi Animal Health Industry Analysis Forum gets a wonderful completion. As a leading part of chemical business in China and a professional B2B platform, Echemi aims to provide better products and services to global chemical companies, and focuses on products price, market trend, and environment-friendly products. In the future, Echemi will stand ready to work with customers all over the world and Chinese suppliers to strengthen cooperation and create potential value. Echemi will bring new concepts and inject new blood to the industry, and its innovation and energy will trigger fast development and prosperity of the industry.

Company Name: Echemi Group

Contact Person: Betha

Email: info@echemi.com

Phone: +86-0532-80905922 / 89072278

Address: 12F, HuaYin Mansion, No.5, Donghai West Road, Qingdao, China

City: Qingdao

Country: China

Website: https://www.echemi.com